No increase in the prevalence of COPD in two decades

European Respiratory Journal

Volumn 36, Issue 4, 2010, Pages 766-773

  Vasankari, T M ^a   Impivaara, O ^b   Heliovaara M ^c   Heistaro, S ^b   Liippo, K ^a   Puukka, P ^b   Saarelainen, S ^d   Kanervisto, M ^e   Jousilahti, P ^b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c Living Conditions   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Bronchial obstruction; Epidemiology; Lower limit of normal; Spirometry; Tobacco smoking

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING HABIT; SPIROMETRY;

ADULT; AGED; AIRWAY OBSTRUCTION; FEMALE; FINLAND; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY MEDICINE; RESPIRATORY FUNCTION TESTS; SMOKING; SPIROMETRY; TIME FACTORS;

EID: 77957850784     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00178109     Document Type: Article

References (32)

1. Anto JM, Vermeire P, Vestbo J, et al. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J 2001; 17: 982-994.
2. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364: 613-620.
3. Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006; 27: 397-412.
4. Davis RM, Novotny TE. The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140: S82-S84.
5. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=2003 Date last updated: December 2009. Date last accessed: April 2009.
6. Miller MR, Pedersen OF, Pellegrino R, et al. Debating the definition of airflow obstruction: time to move on? Eur Respir J 2009; 34: 527-528.
7. 1/FVC ratio below the fifth percentile, not 70%. Chest 2007; 131: 349-355.
8. 1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63: 1046-1051.
9. 1/FVC, 70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax 2008; 63: 1040-1045.
10. Vollmer WM, Gislason Th, Burney P, et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J 2009; 34: 588-597.
11. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-750.
12. Aromaa A, Heliövaara M, Impivaara O, et al. Terveys, toimintakyky ja hoidontarve Suomessa [in Finnish with English summary]. Helsinki, Publications of the National Public Health Institute AL, 1989.
13. von Hertzen L, Reunanen A, Impivaara O, et al. Airway obstruction in relation to symptoms in chronic respiratory disease - a nationally representative population study. Respir Med 2000; 94: 356-363.
14. Heistaro S, ed. Methodology Report. Health 2000 Survey. Publications of the National Public Health Institute B 26/2008. Helsinki, National Public Health Institute, 2008.
15. Aromaa A, Koskinen S, eds. Health and Functional Capacity in Finland. Baseline Results of the Health 2000 Health Examination Survey. Publications of the National Public Health Institute B12/2004. Helsinki, National Public Health Institute, 2004.
16. Pellegrino RC, Viegi G, Brusasco V, et al. Interpretive strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
17. Brändli O, Schindler Ch, Künzli N, et al. Lung function in healthy never smoking adults: reference values and lower limits of normal of a Swiss population. Thorax 1996; 51: 277-283.
18. Hyatt R, Cowl C, Bjoraker J, et al. Conditions associated with an abnormal nonspecific pattern of pulmonary function tests. Chest 2009; 135: 419-424.
19. SUDAAN Language Manual, Release 9.0. Research Triangle Park, Research Triangle Institute, 2004.
20. Vartiainen E, Laatikainen T, Peltonen M, et al. Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 2010; 39: 504-418.
21. Laatikainen T, Critchley J, Vartiainen E, et al. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol 2005; 162: 764-773.
22. Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax 2000; 55: 32-38.
23. Chakrabarti B, Calverley PMA, Davies PDO. Tuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary disease. Int J COPD 2007; 2: 263-272.
24. Härö AS. Cohort approach in tuberculosis surveillance: comparison of the situation in Sweden and Finland. Tuber Lung Dis 1994; 75: 271-282.
25. Tala-Heikkilä M. Tuberculosis in Finland [article in Finnish]. Duodecim 2003; 119: 1621-1628.
26. Murtaugh E, Heaney L, Gingles J, et al. The prevalence of obstructive lung disease in a general population sample: The NICECOPD study. Eur J Epidemiol 2005; 20: 443-453.
27. Hedman J, Kaprio J, Poussa T, et al. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999; 28: 717-722.
28. Kotaniemi J, Sovijärvi A, Lundbäck B. Chronic obstructive pulmonary disease in Finland: prevalence and risk factors. COPD 2005; 2: 331-339.
29. Lindström M, Jönsson E, Larsson K, et al. Underdiagnosis of chronic obstructive pulmonary disease in Northern Sweden. Int J Tuberc Lung Dis 2001; 6: 76-84.
30. Johannessen A, Omenaas E, Bakke P, et al. Incidence of GOLD-defined chronic obstructive pulmonary disease in a general adult population. Int J Tuberc Lung Dis 2005; 9: 926-932.
31. Tzanakis N, Anagnostopoulou U, Filaditaki V, et al. Prevalence of COPD in Greece. Chest 2004; 125: 892-900.
32. Shahab L, Jarvis M, Britton J, et al. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax 2006; 61: 1043-1047.